Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.
Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.
Mark LaLeike’s 25 years of Healthcare and Life Sciences experience includes a diverse set of global pharmaceutical companies as well as large US-based providers and Pharmacy Benefit Managers. He is currently Managing Director, Scientific Commercialization with responsibility for the firm’s Consulting Practice and Analytics as a Service offerings.
In Life Sciences, Mark has worked with senior leaders from clinical development, medical affairs and commercial to define strategic initiatives and oversee implementation of various programs, e.g., new-market entry and product launch; cross-functional capability development; and, operational excellence initiatives. Over the last 5 years, Mark has focused on the convergence of Healthcare and Life Sciences to help attain shared outcomes across patients, payers, providers and manufacturers. Mark has led projects – sponsored by various Payers, Providers and Manufacturers – to help derive tangible benefits from this convergence. These projects include development of a Real-World Evidence Platform, creation of performance-based contract frameworks, and design of population-health collaborations.
At Scientific Commercialization, Mark leads the firm’s development of consulting and analytics offerings that enable Medical Affairs to strengthen their alignment with internal stakeholders and optimize impact with payers, patients and providers.
Prior to joining Scientific Commercialization, Mark was a Managing Director at Accenture where he led the Specialty Biopharm Client Service Group and the Life Science Analytics practice. He received his Bachelor’s degree from DePauw University and a Master’s degree from Indiana University. Mark lives in the Philadelphia area and outside of work, enjoys swimming, cycling and rowing.